Axiom_20Years_Updated logo.jpg
Axiom Presents "Unified Platforms: Streamlining your Start-Up and Submission for Expedited Vaccine Trials" at Vaccines Virtual Conference 2021
August 03, 2021 10:42 ET | Axiom Real-Time Metrics Inc
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations, will...
ibn-iw-globe-2.png
InvestorBrandNetwork Announces The Dealmaker Show Interview with Tryp Therapeutics Inc. CEO Greg McKee
August 03, 2021 08:00 ET | InvestorBrandNetwork (IBN)
LOS ANGELES, Aug. 03, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities, today announces...
Hexagons.png
Evrys Bio Awarded $34 Million from DOD to Develop a Single Drug Simultaneously Effective Against Multiple Lethal Viruses
July 13, 2021 00:04 ET | Evrys Bio
DOYLESTOWN, Pa., July 13, 2021 (GLOBE NEWSWIRE) -- Evrys Bio, a biotech company developing Next Gen Antivirals, was awarded a $34.3 million contract from the Department of Defense (DOD) to develop a...
wpd.jpg
WPD Pharmaceuticals’ Licensor Receives FDA Fast Track Designation for Berubicin for the Treatment of Recurrent Glioblastoma Multiforme; WPD Poland Arranges Loans
July 12, 2021 07:30 ET | WPD Pharmaceuticals
VANCOUVER, British Columbia, July 12, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, is pleased to...
QMI-Logo-Long-1000px.jpg
Global Ophthalmic Therapeutic Drugs Market Size to Grow at a CAGR of 5.8% from 2021 to 2030
July 09, 2021 05:30 ET | Quince Market Insights
Pune, India, July 09, 2021 (GLOBE NEWSWIRE) -- The global ophthalmic therapeutic drugs market was valued at USD 37,500.2 million in 2020 and is projected to grow at a CAGR of 5.8% during the...
SRI International Enters Drug Discovery and Research Collaboration with Sanofi
July 07, 2021 09:05 ET | SRI International
MENLO PARK, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- SRI International (SRI) today announced that the company has entered a research collaboration with Sanofi. By leveraging SRI’s SynFini™...
visiongain Logo.png
European Antibiotics Market Size Worth US$17,778.6 Million by 2031: Visiongain Research, Inc.
July 01, 2021 12:00 ET | Visiongain Ltd
Visiongain has published a new report on “European Antibiotics Market 2021-2031”. Forecasts by Drug Class (Cephalosporin, Fluoroquinolone, Penicillin, Carbapenem, Macrolide, Sulfonamide, Amino...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Differentiated by Clinical Trials, World-Class Management
July 01, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, July 01, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announces the availability of a broadcast titled, “GW Pharma Sells for Bilions;...
trypf.png
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Charting Its Own Course in Psychedelic Space
June 30, 2021 08:30 ET | Tryp Therapeutics Inc.
NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"),...
wpd.jpg
WPD Pharmaceuticals Plans to Commence Phase Ib/II Study of Berubicin for the Treatment of Glioblastoma in 2H 2021
June 28, 2021 07:30 ET | WPD Pharmaceuticals
VANCOUVER, British Columbia, June 28, 2021 (GLOBE NEWSWIRE) -- WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or “WPD”) a clinical-stage pharmaceutical company, today provided an...